Research ArticleHuman Studies
Early Treatment Response in Malignant Lymphoma, as Determined by Planar Fluorine-18-Fluorodeoxyglucose Scintigraphy
Otto S. Hoekstra, Gert J. Ossenkoppele, Richard Golding, Arthur van Lingen, Gerard W.M. Visser, Gerritt J.J. Teule and Peter C. Huijgens
Journal of Nuclear Medicine October 1993, 34 (10) 1706-1710;
Otto S. Hoekstra
Gert J. Ossenkoppele
Richard Golding
Arthur van Lingen
Gerard W.M. Visser
Gerritt J.J. Teule
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Early Treatment Response in Malignant Lymphoma, as Determined by Planar Fluorine-18-Fluorodeoxyglucose Scintigraphy
Otto S. Hoekstra, Gert J. Ossenkoppele, Richard Golding, Arthur van Lingen, Gerard W.M. Visser, Gerritt J.J. Teule, Peter C. Huijgens
Journal of Nuclear Medicine Oct 1993, 34 (10) 1706-1710;
Early Treatment Response in Malignant Lymphoma, as Determined by Planar Fluorine-18-Fluorodeoxyglucose Scintigraphy
Otto S. Hoekstra, Gert J. Ossenkoppele, Richard Golding, Arthur van Lingen, Gerard W.M. Visser, Gerritt J.J. Teule, Peter C. Huijgens
Journal of Nuclear Medicine Oct 1993, 34 (10) 1706-1710;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Chemotherapy Response Evaluation in Metastatic Colorectal Cancer with FDG PET/CT and CT Scans
- PET/CT for Therapy Response Assessment in Lymphoma
- Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography for Interim Response Assessment of Advanced-Stage Hodgkin's Lymphoma and Diffuse Large B-Cell Lymphoma: A Systematic Review
- 18F-FDG PET/CT for Monitoring the Response of Lymphoma to Radioimmunotherapy
- FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma
- The contribution of PET/CT to improved patient management
- Decreased 18F-FDG Uptake 1 Day After Initiation of Chemotherapy for Malignant Lymphomas
- Positron Emission Tomography in Non-Hodgkin's Lymphoma: Assessment of Chemotherapy With Fluorodeoxyglucose